跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RELPAX 20MG TABLET - SFDA Drug Approval Details
Approvals
/
SFDA
/
RELPAX 20MG TABLET
Authorized
NCE
RELPAX 20MG TABLET
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
7df21ddf5e30d232
Company
Unknown
Type
NCE
Approval Details
Approval Id
7df21ddf5e30d232
Drug Approval Sfda Name
RELPAX 20MG TABLET
Trade Name
RELPAX 20MG TABLET
Generic Name
ELETRIPTAN
Register Number
65-892-17
Register Year
2017
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
3
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 25°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
7000000442-20-100000073665
Price
58.2
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
7df21ddf5e30d232
Type
NCE
Back to SFDA Approvals